Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BIOTAPE: TNFi Tapering in Axial Spondyloarthritis
NCT05115903Phase 4Active, not recruiting
- Sponsor
- University Health Network
- Start
- Dec 2021
- Primary completion
- Jul 2024
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial in axial spondyloarthritis (axSpA), sponsored by University Health Network. Primary endpoint: Proportion of patients able to maintain inactive disease or low disease activity at 48 weeks. Started Dec 2021; status: active, not recruiting.
02
Conditions
axial spondyloarthritis (axSpA)
Beyond the preview
Go deeper on NCT05115903.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05115903.